Acute coronary syndrome in patients with cancer: features of the course and the possibility of predicting hospital and long-term (6 months) periods using GDF-15, NT-proBNP, hs-CRP biomarkers

Aim    To evaluate clinical features of the course of acute coronary syndrome (ACS) in patients with oncological diseases (OD) and to determine the role of biomarkers GDF-15, NT-proBNP, and hs-CRP in short-term and long-term prognoses.
Material and methods    In 88 patients (34 patients with ACS and OD and 54 patients with ACS without OD), complaints and historical, objective, and laboratory and instrumental data were evaluated and blood concentrations of GDF-15, NT-proBNP, and hs-CRP biomarkers were measured on the first day of hospitalization. Incidence of cardiovascular complications (CVC) and outcomes of hospital and long-term (6 months) periods were analyzed. Statistical analysis of results was performed with the Statistica 12.0, MedCalc 19.1.7 software. The level of statistical significance was р<0.05.
Results    In the ACS+OD group as compared to the ACS without OD group, the onset of disease was mostly atypical, with shortness of breath and/or general weakness; the ACS+OD patients more frequently had III-IV Killip class acute heart failure (29 and 7 %, р=0.01); mean hemoglobin concentration (125.6±27.9 and 141±16.6 g/l, р=0.003), prothrombin index (76.4±15.2 and 84.9±17.6 %, р=0.003), and left ventricular ejection fraction (47.7±6.1 and 50.7±7.2 %, р=0.02) were lower; and median concentrations of GDF-15 (1.95 [1.3; 2.8] and 1.45 [1.2; 2.0] ng/ml, р=0.03), NT-proBNP (947.3 [517.8; 1598.2], and 491.1 [85.1; 1069.1] pg/ml, р=0.006), and hs-CRP (14.1 [8.15; 36.75] and 7.8 [4.4; 16.2] mg/l, р=0.01) were higher. The presence of OD was associated with development of CVC, including urgent endpoints in the long-term and also increased the probability of fatal outcome within 6 months after discharge from the hospital. To predict the risk of CVC in patients with ACS and OD, two models with high prognostic values (AUC>0.9) were proposed. In the long-term, the value of NT-proBNP (cut-off point >524.5 pg/ml) was a statistically significant predictor for development of endpoints with a high predictive value (AUC>0.8).
Conclusion    The features of the clinical course of ACS in patients with OD indicate the importance of isolating such patients into a separate group. Additional use of the developed models, along with a standard risk assessment by the GRACE scale, will allow individualized management of patients with ACS and OD during the hospital and long-term (6 months) periods.

1. Sturgeon KM, Deng L, Bluethmann SM, Zhou S, Trifiletti DM, Jiang C et al. A population-based study of cardiovascular disease mortality risk in US cancer patients. European Heart Journal. 2019;40(48):3889–97. DOI: 10.1093/eurheartj/ehz766

2. Balluzek M.F., Ionova A.K. Cardio-oncology in treatment and rehabilitation programs of oncological patients. Russian Journal of Cardiology. 2014;19(5):75–80. DOI: 10.15829/1560-4071-2014-5-75-80

3. Velders MA, Boden H, Hofma SH, Osanto S, van der Hoeven BL, Heestermans AACM et al. Outcome After ST Elevation Myocardial Infarction in Patients with Cancer Treated with Primary Percutaneous Coronary Intervention. The American Journal of Cardiology. 2013;112(12):1867–72. DOI: 10.1016/j.amjcard.2013.08.019

4. Iannaccone M, D’Ascenzo F, Vadalà P, Wilton SB, Noussan P, Colombo F et al. Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudy. European Heart Journal: Acute Cardiovascular Care. 2018;7(7):631–8. DOI: 10.1177/2048872617706501

5. Esc Study Group. The task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Russian Journal of Cardiology. 2018;23(5):103–58. DOI: 10.15829/1560-4071-2018-5-103-158

6. Roffi M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Russian Journal of Cardiology. 2016;23(3):9–63.

7. Alieva M.G. Risk stratification, registers and prognostic scales in acute coronary syndrome. South of Russia: Ecology, Development. 2017;12(3):159–65.

8. Zhang S, Dai D, Wang X, Zhu H, Jin H, Zhao R et al. Growth differentiation factor–15 predicts the prognoses of patients with acute coronary syndrome: a meta-analysis. BMC Cardiovascular Disorders. 2016;16(1):82. DOI: 10.1186/s12872-016-0250-2

9. Zimmers TA, Jin X, Hsiao EC, McGrath SA, Esquela AF, Koniaris LG. Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury. Shock (Augusta, Ga.). 2005;23(6):543–8. PMID: 15897808

10. Khorolets E.V., Shlyk S.V. Evaluation prediction heart failure in patients with myocardial infarction in period of hospital treatment. Modern problems of science and education. 2018;4:162–72.

11. López-Sendón J, Álvarez-Ortega C, Zamora Auñon P, Buño Soto A, Lyon AR, Farmakis D et al. Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry. European Heart Journal. 2020;41(18):1720–9. DOI: 10.1093/eurheartj/ehaa006

12. Li Y, Zhong X, Cheng G, Zhao C, Zhang L, Hong Y et al. Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis. Atherosclerosis. 2017;259:75–82. DOI: 10.1016/j.atherosclerosis.2017.02.003

13. Kopitsa N.P., Vishnevskaya I.R. Predicting death in patients with acute coronary outcome in the nearest and remote periods. ScienceRise. 2014;5(4(5)):7–10. DOI: 10.15587/2313-8416.2014.31916

14. Widera C, Pencina MJ, Meisner A, Kempf T, Bethmann K, Marquardt I et al. Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in nonST-elevation acute coronary syndrome. European Heart Journal. 2012;33(9):1095–104. DOI: 10.1093/eurheartj/ehr444

15. Khamitova A.F., Lakman I.A., Akhmetvaleev R.R., Tulbaev E.L., Gareeva D.F., Zagidullin Sh.Z. et al. Multifactor predictive model in patients with myocardial infarction based on modern biomarkers. Kardiologiia. 2020;60(3):14–20. DOI: 10.18087/cardio.2020.3.2593

16. StatSoft, Inc. Electronic textbook on statistics. Moscow. StatSoft. 2012. Av. at: http://statsoft.ru/home/textbook/default.htm.

17. Luboyatnikova E.S., Kiselev A.R., Komarova M.V., Rodionova V.A., Kapp E.V., Duplyakov D.V. ST-Elevation Myocardial Infarction in Patients with Malignancies. Kardiologiia. 2018;58(12):5–12. DOI: 10.18087/cardio.2018.12.10204

18. Putt M, Hahn VS, Januzzi JL, Sawaya H, Sebag IA, Plana JC et al. Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab. Clinical Chemistry. 2015;61(9):1164–72. DOI: 10.1373/clinchem.2015.241232

19. Trusheva K.S., Bajbolova M.K., Toktarbaeva A.A. Cardio-oncology: anti-cancer treatment and cardiovascular outcomes. Achievements of science and education. 2018;6(28):96–9.

20. Shitara J, Ogita M, Wada H, Tsuboi S, Endo H, Doi S et al. Clinical impact of high-sensitivity C-reactive protein during follow-up on longterm adverse clinical outcomes in patients with coronary artery disease treated with percutaneous coronary intervention. Journal of Cardiology. 2019;73(1):45–50. DOI: 10.1016/j.jjcc.2018.06.002

21. Shalenkova M.A., Ivanov A.V., Klimkin P.F., Rumyantseva S.M., Mironov N.N. A method for predicting urgent cardiovascular complications in the hospital period with acute coronary syndrome in patients with a history of cancer. Patent RU 2 741 195 C1. 2021. Av. at: https://patenton.ru/patent/RU2741195C1.

22. Collet JP, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Russian Journal of Cardiology. 2021;26(3):125–93. DOI: 10.15829/1560-4071-2021-4418